David Weber is the founder of Otonomy. Otonomy has raised $94M in total funding. Latest round: Series D. Backed by Avalon Ventures.
David A. Weber, Ph.D., is the Chief Executive Officer of Otonomy, a clinical-stage biopharmaceutical company focused on ear therapeutics. He served as CEO during Otonomy's Series C ($45.9M) and Series D ($49M) financing rounds, advancing the company's ear-therapy products.
Full founder directory · Investor directory · Company funding database · Fundraising library